...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: CALGARY, Alberta, March 02, 2023 - Resverlogix Corp.

RESVERLOGIX ANNOUNCES NEW RESEARCH HIGHLIGHTING APABETALONE’S POTENTIAL BENEFITS IN CARDIOVASCULAR DISEASE, HEART FAILURE, AND COVID-19

https://www.resverlogix.com/investors/news.html?article=722

 

Koo

 

 

Share
New Message
Please login to post a reply